Next Article in Journal
Hydrogen-Bonded Organic–Inorganic Hybrid Based on Hexachloroplatinate and Nitrogen Heterocyclic Cations: Their Synthesis, Characterization, Crystal Structures, and Antitumor Activities In Vitro
Next Article in Special Issue
Lichen Xanthones as Models for New Antifungal Agents
Previous Article in Journal
In Vitro Antioxidant Activities of Phenols and Oleanolic Acid from Mango Peel and Their Cytotoxic Effect on A549 Cell Line
Open AccessCommunication

The Design and Synthesis of N-Xanthone Benzenesulfonamides as Novel Phosphoglycerate Mutase 1 (PGAM1) Inhibitors

Department of Medicinal Chemistry, School of Pharmacy, Fudan University, No. 826, Zhangheng Rd., Shanghai 201203, China
*
Authors to whom correspondence should be addressed.
Molecules 2018, 23(6), 1396; https://doi.org/10.3390/molecules23061396
Received: 13 May 2018 / Revised: 1 June 2018 / Accepted: 4 June 2018 / Published: 8 June 2018
Upregulation of phosphoglycerate mutase 1 (PGAM1) has been identified as one common phenomenon in a variety of cancers. Inhibition of PGAM1 provides a new promising therapeutic strategy for cancer treatment. Herein, based on our previous work, a series of new N-xanthone benzenesulfonamides were discovered as novel PGAM1 inhibitors. The representative molecule 15h, with an IC50 of 2.1 μM, showed an enhanced PGAM1 inhibitory activity and higher enzyme inhibitory specificity compared to PGMI-004A, as well as a slightly improved antiproliferative activity. View Full-Text
Keywords: phosphoglycerate mutase 1; inhibitors; anti-cancer; xanthone phosphoglycerate mutase 1; inhibitors; anti-cancer; xanthone
Show Figures

Graphical abstract

MDPI and ACS Style

Wang, P.; Jiang, L.; Cao, Y.; Ye, D.; Zhou, L. The Design and Synthesis of N-Xanthone Benzenesulfonamides as Novel Phosphoglycerate Mutase 1 (PGAM1) Inhibitors. Molecules 2018, 23, 1396.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

1
Back to TopTop